Israel antirheumatic drugs market was valued at US$143.570 million in 2019. The market in Israel is poised to show decent growth over the course of the next five years due to rapid growth in the private healthcare spending of the country which is further anticipated to drive the demand for numerous treatments, medical services, and medicines among others. According to data by the Israel Central Bureau of Statistics, the proportion of private spending reached 40%, thus indicating a rise i Read more...
Japan antirheumatic drugs market was valued at US$1,353.154 million in 2019. The market growth is majorly being driven by the continuously increasing elderly population in this country. According to the World Bank Group data, the percentage of the total population, age 65 and above, has increased from 16.98% in 2000 to 27.58% in 2018 in this country. The state-of-the-art healthcare system in this country is contributing to this growing number, which, as a result, is increasing the burden Read more...
The Middle East and Africa (MEA) antirheumatic drugs market was valued at US$10,727.154 million in 2019. The market in the Middle East and Africa region is poised to show healthy growth throughout the forecast period primarily on account of the presence of a well-established and state-of-art pharmaceutical industry in the region. The presence of a vast number of domestic pharmaceutical manufacturing companies is also considered to be a major factor driving the antirheumatic drugs market Read more...
North America Antirheumatic Drugs market was valued at US$8,988.317 million in 2019. The booming aging population in countries like the United States and Canada is the major driver of the antirheumatic drugs market in this region. According to the United States Census Bureau, all baby boomers will be older than age 65 by 2030, expanding the size of the older population such that 1 in every 5 residents will be at retirement age. According to the data provided by the Government of Canada, Read more...
Mexico Antirheumatic Drugs market was valued at US$2,389.634 million in 2019. Rising Mexican population suffering from arthritis is the major driver of the antirheumatic drugs market in Mexico. Arthritis does not affect only the elderly population, lifestyle, and work influence also results in the development of arthritis in adults. As such, the growing working population with a sitting job is also leading to the rising prevalence of arthritis in Mexico, thereby fuelling the antirheumati Read more...
Saudi Arabia antirheumatic drugs market was valued at US$517.880 million in 2019. The antirheumatic drugs market in Saudi Arabia is projected to show nominal growth throughout the forecast period owing to the low prevalence of arthritis in the country. However, the growth in the country may be attributed to the presence of a state-of-art healthcare system of the country. Saudi Arabia is one of the most prominent countries of the MEA region Saudi Arabian region regarding the development o Read more...
South America Antirheumatic Drugs market was valued at US$7,074.415 million in 2019. Countries like Brazil, Argentina, Peru, and Colombia are witnessing a continuous rise in the number of people suffering from chronic diseases. According to the World Health Organization, the total prevalence of diabetes in Argentina is 10.2% of the country’s total population. As such, the prevalence of arthritis is also increasing in the region, thus driving the antirheumatic drugs market in South Read more...
South Korea antirheumatic drugs market was valued at US$663.833 million in 2019. The growth of the marketin this country is majorly attributed to the growing geriatric population on account of a good healthcare system across the country. According to data from the World Bank Group, the proportion of South Korean population aged 65 and above was 7.51% in 2001, and this number had risen to 14.42% in 2018. Since this age group is more prone to getting rheumatoid arthritis, and even if someo Read more...
Spain antirheumatic drug market was valued at US$800.242 million in 2019. Spain is the 14th largest economy in the world and the 5th in the European Union, even after years of economic recession Spain marked the third straight year of at least 3% of GDP growth becoming one of the fastest-growing economies in the European Union and recently country is developed into one of the top players in the European pharmaceutical industry. The pharmaceutical industry has been increasing its investme Read more...
France Antirheumatic drugs market was valued at US$1,095.785 million in 2019. The antirheumatic drugs market in France is poised to grow on account of the high government support in the country for providing better healthcare services to the citizens along with the presence of a well-established healthcare sector of the country. The majority of the health expenditure of the country is government-funded which further enables the citizens to afford costly treatments and medicines which is Read more...
.jpg)
